Correction to: Evaluation of Bruton tyrosine kinase inhibitors monotherapy and combination therapy in lymphocytic leukemia

Correction to: Clinical and Experimental Medicine https://doi.org/10.1007/s10238-023-01208-9

In the original version of this article, co-author names were missing. The correct author groups and affiliations should have been

Xiangxing Liu1,2, Binyi Hu1,2, Nan Peng3, Liming Chen4, Dingyuan Hu2,5, Jiaojiao Zhang1,2, Lijue Wang2,·Zhenwei Xie2, Suping Niu6, Qian Lu7, Jin Lu3, Yi Fang2

1Department of Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Yunlong District, Xuzhou, Jiangsu 221004, China

2Clinical Trial Institution, Peking University People’s Hospital, Beijing 100044, China

3Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China;

4Nursing Department, Peking University People’s Hospital, Beijing 100044, China

5Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China

6Clinical Trial institution, Scientific Research Department, Peking University People’s Hospital, Beijing 100044, China

7Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Yunlong District, Xuzhou 221004, Jiangsu, China

The original article has been corrected.

Comments (0)

No login
gif